Clinical Trials
4 trialsNCT01340976 2018-10-03
A Phase 1 Study of LY2787106 in Cancer and Anemia
Eli Lilly and Company
Phase 1 Completed
NCT01280240 2013-06-04
PK-CIA-06
Pharmacosmos A/S
Phase 1 Completed
NCT00097747 2012-12-21
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
Affymax
Phase 1 Completed
NCT00629876 2011-12-01
A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.
Takeda
Phase 1 Terminated